Jim McKenney - Vice President Global Sales, Celluma by BioPhotas Jim McKenney joined BioPhotas in August of 2019 to manage the company’s dramatic international growth and develop new global markets for the award winning Celluma SERIES of LED devices. Jim brings more than 20 years of leadership experience in business development and sales management. He has worked with some of the world’s largest and most successful healthcare companies and has a proven track record with… Read more...
Keck School of Medicine of USC and Science 37 Collaborate on Largest Ever NIH-Funded, Telemedicine-Based Dermatology Study The two organizations will compare care methods for treating patients with eczema LOS ANGELES, October 1, 2019 — Science 37, the industry leader in virtual clinical trials, and the Keck School of Medicine of the University of Southern California (USC) recently announced a partnership agreement that will support the execution of a $3.4 million study funded by the National Institutes of Health (NIH)—the largest telemedicine-based… Read more...
Raison d’Etre Speaks on Wellness Opportunities for Ecuador This past summer, Ian Bell, senior project manager for global spa consultancy and think tank, Raison d’Etre, was invited by Mònica Alatorre, dean of hospitality and tourism at UDLA in Quito, Ecuador, to give a presentation to 31 fourth year students currently visiting Puerto Ayora, Galapagos. Bell focused the lecture on the global wellness industry, the current global wellness trends, and, more specifically, the current… Read more...
Raison d’Etre Awarded Scandinavia’s Best Wellness Concept and Brand Creator Global spa consultancy Raison d’Etre has been awarded the distinguished title of Best Wellness Concept and Brand Creator for Scandinavia in the LUX 2019 Hotel and Spa Awards. The Awards by LUX Life Magazine looks to honor candidates who stand out from the competition and work tirelessly to provide their guests with seamless and tranquil wellness experiences. The award win honors the Stockholm, Sweden-based consultancy’s… Read more...
Philips Global Beauty Index Reveals that Women Want Personalized Beauty Solutions Royal Philips released the findings of its fifth annual Philips Global Beauty Index, surveying over 12,000 women from 12 different countries. The extensive international study explores the attitudes and perceptions of women from around the globe to uncover how they define beauty, the role it plays in their lives, and how the industry is supporting them. This year, Philips gazed into the future, examining the… Read more...
Color Up Therapeutics Now Approved in Oncology Color Up is officially oncology-approved by Oncology Spa Solutions. All products were tested in three hospitals on oncology patients and by therapists (aestheticians and massage therapists) using them on patients. Color Up COO and co-owner Shauna Blanch says, “We started on this journey to help people find mental, physical and emotional healing, wellness, and balance through the cannabis plant. After many years of hard work,… Read more...
W. Larry Kenney Educates on Impact of Ultraviolet Radiation on Athletes at Conference The dangers of ultraviolet radiation exposure, which most often comes from the sun, are well-known. At The Physiological Society’s Extreme Environmental Physiology conference, recently, W. Larry Kenney of Penn State University discussed how broad its effects can be, from premature aging to cancer, and how this can be influenced by different skin tones and the use of sunscreen. Athletes ranging from hikers to tennis players… Read more...
Cassiopea SpA Developing New Prescription Drugs for Dermatological Conditions Cassiopea SpA, a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action to address long-standing and essential dermatological conditions, announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) seeking marketing approval for clascoterone cream 1% for the treatment of acne. Clascoterone cream 1% is under investigation as a first-in-class, topical androgen… Read more...